Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 179

1.

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597.

Lund A, Bagger JI, Wewer Albrechtsen NJ, Christensen M, Grøndahl M, Hartmann B, Mathiesen ER, Hansen CP, Storkholm JH, van Hall G, Rehfeld JF, Hornburg D, Meissner F, Mann M, Larsen S, Holst JJ, Vilsbøll T, Knop FK.

Diabetes. 2016 Jun;65(6):1752. doi: 10.2337/db16-er06. No abstract available.

PMID:
27222398
2.

Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.

Fontes-Villalba M, Lindeberg S, Granfeldt Y, Knop FK, Memon AA, Carrera-Bastos P, Picazo Ó, Chanrai M, Sunquist J, Sundquist K, Jönsson T.

Cardiovasc Diabetol. 2016 May 23;15(1):80. doi: 10.1186/s12933-016-0398-1.

3.

Diabetes and obesity treatment based on dual incretin receptor activation - "twincretins".

Skow MA, Bergmann NC, Knop FK.

Diabetes Obes Metab. 2016 May 10. doi: 10.1111/dom.12685. [Epub ahead of print] Review.

PMID:
27160961
4.

Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study.

Munch L, Arreskov AB, Sperling M, Overgaard D, Knop FK, Vilsbøll T, Røder ME.

BMC Health Serv Res. 2016 Apr 9;16(1):124. doi: 10.1186/s12913-016-1365-y.

5.

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.

Rohde U, Sonne DP, Christensen M, Hansen M, Brønden A, Toräng S, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.

J Clin Endocrinol Metab. 2016 May;101(5):2076-83. doi: 10.1210/jc.2016-1133. Epub 2016 Mar 22.

PMID:
27003305
6.

GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes.

Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T.

Diabetes Care. 2016 Apr;39(4):617-24. doi: 10.2337/dc15-2383. Epub 2016 Feb 23.

PMID:
26908914
7.

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.

Hansen M, Scheltema MJ, Sonne DP, Hansen JS, Sperling M, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.

Diabetes Obes Metab. 2016 Jun;18(6):571-80. doi: 10.1111/dom.12648. Epub 2016 Mar 22.

PMID:
26888164
8.

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.

Wewer Albrechtsen NJ, Veedfald S, Plamboeck A, Deacon CF, Hartmann B, Knop FK, Vilsboll T, Holst JJ.

J Diabetes Res. 2016;2016:8352957. doi: 10.1155/2016/8352957. Epub 2015 Dec 29.

9.

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature.

Mikkelsen KH, Allin KH, Knop FK.

Diabetes Obes Metab. 2016 May;18(5):444-53. doi: 10.1111/dom.12637. Epub 2016 Mar 4. Review.

PMID:
26818734
10.

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.

Junker AE, Gluud L, Holst JJ, Knop FK, Vilsbøll T.

J Intern Med. 2016 May;279(5):485-93. doi: 10.1111/joim.12462. Epub 2016 Jan 5.

PMID:
26728692
11.

GLP-1 and Amylin in the Treatment of Obesity.

Jorsal T, Rungby J, Knop FK, Vilsbøll T.

Curr Diab Rep. 2016 Jan;16(1):1. doi: 10.1007/s11892-015-0693-3. Review.

PMID:
26699764
12.

Evidence of Extrapancreatic Glucagon Secretion in Man.

Lund A, Bagger JI, Wewer Albrechtsen NJ, Christensen M, Grøndahl M, Hartmann B, Mathiesen ER, Hansen CP, Storkholm JH, van Hall G, Rehfeld JF, Hornburg D, Meissner F, Mann M, Larsen S, Holst JJ, Vilsbøll T, Knop FK.

Diabetes. 2016 Mar;65(3):585-97. doi: 10.2337/db15-1541. Epub 2015 Dec 15.

PMID:
26672094
13.

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.

Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U, Jensen T, Jensen AK, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU.

Lancet Diabetes Endocrinol. 2016 Mar;4(3):221-32. doi: 10.1016/S2213-8587(15)00436-2. Epub 2015 Dec 3.

PMID:
26656289
14.

Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease.

Junker AE, Gluud LL, van Hall G, Holst JJ, Knop FK, Vilsbøll T.

J Hepatol. 2016 Apr;64(4):908-15. doi: 10.1016/j.jhep.2015.11.014. Epub 2015 Nov 25.

PMID:
26626496
15.

Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867.

Sonne DP, Knop FK.

Diabetes Care. 2015 Dec;38(12):e215. doi: 10.2337/dc15-1794. No abstract available.

PMID:
26604291
16.

N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.

Hansen LS, Sparre-Ulrich AH, Christensen M, Knop FK, Hartmann B, Holst JJ, Rosenkilde MM.

Br J Pharmacol. 2016 Mar;173(5):826-38. doi: 10.1111/bph.13384. Epub 2016 Jan 30.

17.

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.

Mikkelsen KH, Frost M, Bahl MI, Licht TR, Jensen US, Rosenberg J, Pedersen O, Hansen T, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK.

PLoS One. 2015 Nov 12;10(11):e0142352. doi: 10.1371/journal.pone.0142352. eCollection 2015.

18.

Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia.

Suppli MP, Lund A, Bagger JI, Vilsbøll T, Knop FK.

Med Hypotheses. 2016 Jan;86:100-3. doi: 10.1016/j.mehy.2015.10.029. Epub 2015 Nov 2.

PMID:
26547273
19.

Response to the Letter: "Epidemiologic Association Between Antibiotic Use With the Risk of Developing Type 2 Diabetes" by López-Hernández, D.

Mikkelsen KH, Knop FK, Frost M, Hallas J, Pottegård A.

J Clin Endocrinol Metab. 2015 Nov;100(11):L121. doi: 10.1210/jc.2015-3552. No abstract available.

PMID:
26544666
20.

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis.

Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK.

Diabetes Obes Metab. 2016 Mar;18(3):300-5. doi: 10.1111/dom.12603. Epub 2016 Jan 15.

PMID:
26537317
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk